Ticker Details
Repligen Corporation Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.
IPO Date:	March 26, 1990
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$10.22B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.31 | 3.17%
Avg Daily Range (30 D):	$2.99 | 2.02%
Avg Daily Range (90 D):	$3.02 | 2.28%

Institutional Daily Volume
Avg Daily Volume:	.32M
Avg Daily Volume (30 D):	1.01M
Avg Daily Volume (90 D):	.99M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	45
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	6,465
Avg Institutional Trade:	$5.25M
Avg Institutional Trade (30 D):	$7M
Avg Institutional Trade (90 D):	$7.02M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$7.89M
Avg Closing Trade (30 D):	$20.71M
Avg Closing Trade (90 D):	$19.6M
Avg Closing Volume:	65.77K

News

Jul 3, 2026 @ 8:42 AM Global Sterile Bioprocess Filtration Market Set to... Source: Researchandmarkets.Com

Jun 25, 2026 @ 9:23 PM Stock Market Today, June 25: Bio-Techne Surges Aft... Source: Josh Kohn-Lindquist

Jan 20, 2026 @ 5:38 PM Single-Use Bioprocessing Market Projected to Reach... Source: Astute Analytica

Jan 16, 2026 @ 5:38 PM Continuous Bioprocessing Market Set to Surpass Val... Source: Astute Analytica

Oct 24, 2025 @ 2:00 PM Filtration in Biologics Market: Trends, Growth Dri... Source: Towards Healthcare

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$.75	$.09	$.15
Diluted EPS	$.73	$.09	$.15
Revenue	$785.1M	$204.13M	$194.26M
Gross Profit	$422.67M	$110.04M	$108.28M
Net Income / Loss	$41.54M	$5.01M	$8.33M
Operating Income / Loss	$64.61M	$13.98M	$15.94M
Cost of Revenue	$362.43M	$94.09M	$85.97M
Net Cash Flow	$-99.53M	$24.48M	$18.76M
PE Ratio